Herzinsuffizienz: Gibt es Geschlechterunterschiede?
暂无分享,去创建一个
[1] V. Regitz-Zagrosek,et al. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[2] E. McNally,et al. The genetics of dilated cardiomyopathy , 2010, Current opinion in cardiology.
[3] V. Regitz-Zagrosek,et al. Heart Transplantation in Women With Dilated Cardiomyopathy , 2010, Transplantation.
[4] V. Regitz-Zagrosek,et al. Regression of Myocardial Hypertrophy After Aortic Valve Replacement: Faster in Women? , 2009, Circulation.
[5] V. Regitz-Zagrosek,et al. 17β-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts , 2009, Cardiovascular research.
[6] S. Russell,et al. The Impact of Donor-Recipient Sex Matching on Survival After Orthotopic Heart Transplantation: Analysis of 18 000 Transplants in the Modern Era , 2009, Circulation. Heart failure.
[7] G. Caldito,et al. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. , 2009, American journal of obstetrics and gynecology.
[8] C. Duvernoy,et al. Influence of gender of physicians and patients on guideline‐recommended treatment of chronic heart failure in a cross‐sectional study , 2009, European journal of heart failure.
[9] R. Erbel,et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. , 2009, Deutsches Arzteblatt international.
[10] Y. Kagaya,et al. Emerging problems of heart failure practice in Japanese women: lessons from the CHART study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[11] K. Laederach-Hofmann,et al. Heart failure events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. , 2008, Swiss medical weekly.
[12] V. Regitz-Zagrosek,et al. Leading article , 1964 .
[13] E. Wellnhofer,et al. Beneficial Effect of Female Gender on Long-Term Survival After Heart Transplantation , 2008, Transplantation.
[14] R. Hetzer,et al. Experience with over 1000 Implanted Ventricular Assist Devices , 2008, Journal of cardiac surgery.
[15] C. Angermann,et al. [Depression in chronic heart failure: complication, risk factor or autonomous disease?]. , 2008, Der Internist.
[16] M. Redaélli,et al. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. , 2008, Journal of women's health.
[17] P. Ponikowski,et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II , 2008, European journal of heart failure.
[18] C. Angermann,et al. Depression and survival in chronic heart failure: Does gender play a role? , 2007, European journal of heart failure.
[19] M. Kochen,et al. Psychological distress in primary care patients with heart failure: a longitudinal study. , 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.
[20] M. Lauer,et al. Long-term prognostic value of peak oxygen consumption in women versus men with heart failure and severely impaired left ventricular systolic function. , 2007, The American journal of cardiology.
[21] M. Komajda,et al. Management of patients with heart failure in clinical practice: differences between men and women , 2007, Heart.
[22] G. Taffet,et al. Coronary Microvascular Dysfunction , 2007 .
[23] J. Fett. Viral infection as a possible trigger for the development of peripartum cardiomyopathy , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[24] V. Regitz-Zagrosek,et al. Estrogens and SERMs in coronary heart disease. , 2007, Current opinion in pharmacology.
[25] K. Sliwa,et al. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy , 2007, Cell.
[26] V. Cuomo,et al. Gender differences in drug responses. , 2007, Pharmacological research.
[27] L. Saul. Cardiac Resynchronization Therapy , 2007, Critical care nursing quarterly.
[28] D. Kass,et al. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial , 2006, Circulation.
[29] Paul J Mills,et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. , 2006, Journal of the American College of Cardiology.
[30] K. Alexander,et al. Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.
[31] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[32] K. Laule-Kilian,et al. Gender differences in acute congestive heart failure. , 2006, Swiss medical weekly.
[33] Vera Regitz-Zagrosek,et al. Therapeutic implications of the gender-specific aspects of cardiovascular disease , 2006, Nature Reviews Drug Discovery.
[34] V. Regitz-Zagrosek,et al. The FASEB Journal • Research Communication Estrogen receptor alpha up-regulation and redistribution in human heart failure , 2022 .
[35] B. Bozkurt,et al. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. , 2006, The American journal of cardiology.
[36] J. Mullooly,et al. Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970–1974 and 1990–1994 , 2006, Circulation.
[37] K. Sliwa,et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. , 2006, European heart journal.
[38] K. Swedberg,et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. , 2005, European heart journal.
[39] R. Karas,et al. Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.
[40] K. Swedberg,et al. Gender Makes a Difference in the Description of Dyspnoea in Patients with Chronic Heart Failure , 2005, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[41] K. Korach,et al. Increased Mortality and Aggravation of Heart Failure in Estrogen Receptor-&bgr; Knockout Mice After Myocardial Infarction , 2005, Circulation.
[42] A. Cohen-Solal,et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.
[43] L. Leinwand,et al. Sex modifies exercise and cardiac adaptation in mice. , 2004, American journal of physiology. Heart and circulatory physiology.
[44] V. Regitz-Zagrosek,et al. Upregulation of Myocardial Estrogen Receptors in Human Aortic Stenosis , 2004, Circulation.
[45] A. di Lenarda,et al. The ‘real’ woman with heart failure. Impact of sex on current in‐hospital management of heart failure by cardiologists and internists , 2004, European journal of heart failure.
[46] M. Cavasin,et al. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. , 2004, Life sciences.
[47] V. Regitz-Zagrosek,et al. Gender aspects in heart failure. Pathophysiology and medical therapy. , 2004, Archives des maladies du coeur et des vaisseaux.
[48] B. Yawn,et al. Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.
[49] Y. Jiang,et al. Testosterone Regulates mRNA Levels of Calcium Regulatory Proteins in Cardiac Myocytes , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[50] C. Yancy,et al. Gender differences in advanced heart failure: insights from the BEST study. , 2003, Journal of the American College of Cardiology.
[51] P. Fitzgerald,et al. Tako-tsubo-like left ventricular dysfunction. , 2003, Circulation.
[52] M. Martínez‐Sellés,et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. , 2003, European heart journal.
[53] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[54] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[55] D. Levy,et al. Obesity and the risk of heart failure. , 2003, The New England journal of medicine.
[56] Harlan M Krumholz,et al. Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.
[57] D. Kass,et al. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.
[58] K. Matthews,et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. , 2003, Journal of the American College of Cardiology.
[59] S Capewell,et al. Heart failure and the aging population: an increasing burden in the 21st century? , 2003, Heart.
[60] Harlan M Krumholz,et al. Sex-based differences in the effect of digoxin for the treatment of heart failure. , 2002, The New England journal of medicine.
[61] Daniel Levy,et al. Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.
[62] Douglas W Mahoney,et al. Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.
[63] R. Karas,et al. The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.
[64] Mark A. Magnuson,et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy , 2002, Nature.
[65] K. Nishioka,et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. , 2002, American heart journal.
[66] H. Hense,et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. , 2002, Cardiovascular research.
[67] J. Manson,et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. , 2001, JAMA.
[68] David Newman,et al. New-Onset Atrial Fibrillation: Sex Differences in Presentation, Treatment, and Outcome , 2001, Circulation.
[69] C. Hayward,et al. Effect of sex hormones on cardiac mass , 2001, The Lancet.
[70] Ennis,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[71] G. Dorn,et al. Interactions Between Phospholamban and &bgr;-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality , 2001, Circulation.
[72] T. Simon,et al. Sex Differences in the Prognosis of Congestive Heart Failure: Results From the Cardiac Insufficiency Bisoprolol Study (CIBIS II) , 2001, Circulation.
[73] D. Kitzman,et al. The pathogenesis of acute pulmonary edema associated with hypertension. , 2001, The New England journal of medicine.
[74] E. Perez. Doxorubicin and Paclitaxel in the Treatment of Advanced Breast Cancer: Efficacy and Cardiac Considerations , 2001, Cancer investigation.
[75] Simon Stewart,et al. Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.
[76] N. Reichek,et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. , 2000, The New England journal of medicine.
[77] R Dietz,et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.
[78] M. Neumann,et al. 17beta-estradiol prevents programmed cell death in cardiac myocytes. , 2000, Biochemical and biophysical research communications.
[79] C. di Loreto,et al. Myocyte death in the failing human heart is gender dependent. , 1999, Circulation research.
[80] R. Solaro,et al. Sexual dimorphism in rat left atrial function and response to adrenergic stimulation , 1999, Molecular and Cellular Biochemistry.
[81] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[82] C. Hengstenberg,et al. Familial predisposition of left ventricular hypertrophy. , 1999, Journal of the American College of Cardiology.
[83] A Hofman,et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.
[84] B. Knollmann,et al. Cardiac actions of erythromycin: influence of female sex. , 1998, JAMA.
[85] A. Moss. Background, outcome, and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) , 1997, The American journal of cardiology.
[86] O. Simell,et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.
[87] W. Catterall,et al. Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice , 1997, The Journal of general physiology.
[88] M. Lehmann,et al. Sex difference in risk of torsade de pointes with d,l-sotalol. , 1996, Circulation.
[89] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[90] P. Anversa,et al. Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.
[91] Daniel L. McGee,et al. Left ventricular hypertrophy has a greater impact on survival in women than in men. , 1995, Circulation.
[92] Y. Palesch,et al. Propranolol metabolism in normal subjects: Association with sex steroid hormones , 1994, Clinical pharmacology and therapeutics.
[93] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[94] S. Coughlin,et al. Descriptive epidemiology of idiopathic dilated cardiomyopathy in Washington County, Maryland, 1975-1991. , 1993, Journal of clinical epidemiology.
[95] R M Lang,et al. Sex‐Associated Differences in Left Ventricular Function in Aortic Stenosis of the Elderly , 1992, Circulation.
[96] A. Tajik,et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.
[97] L. Melton,et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.
[98] R. Gillum. Idiopathic cardiomyopathy in the United States, 1970-1982. , 1986, American heart journal.
[99] K. Rasmussen,et al. Cardiomyopathy in western Denmark. , 1984, British heart journal.
[100] M. Kendall,et al. Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill. , 1984, British journal of clinical pharmacology.
[101] M. Kendall,et al. Metoprolol pharmacokinetics and the oral contraceptive pill. , 1982, British journal of clinical pharmacology.
[102] D. Mattison,et al. Sex Differences in Pharmacokinetics and Pharmacodynamics , 2009, Clinical pharmacokinetics.
[103] V. Regitz-Zagrosek,et al. [Gender differences in psychopharmacology]. , 2008, Der Internist.
[104] V. Regitz-Zagrosek,et al. [Sex differences in cardiovascular drug targeting]. , 2008, Der Internist.
[105] V. Regitz-Zagrosek,et al. Role of gender in heart failure with normal left ventricular ejection fraction. , 2007, Progress in cardiovascular diseases.
[106] D. Edwards. Regulation of signal transduction pathways by estrogen and progesterone. , 2005, Annual review of physiology.
[107] R. Kormos,et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[108] James A. Clark,et al. Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy , 2005 .
[109] H. Hense. [Epidemiology of arterial hypertension and implications for its prevention. 10-yeart results of the MONICA Study Augsburg]. , 2000, Deutsche Medizinische Wochenschrift.
[110] R. Mann,et al. Cough and angiotensin II receptor antagonists: cause or confounding? , 1999, British journal of clinical pharmacology.
[111] M. Lehmann,et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.
[112] Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.
[113] B. I. Barbero. [Heart diseases in pregnancy]. , 1958, Anales de cirugia.